Table 2:
Predominant Immune Mechanism | POAG % (n = 172) | Controls % (n = 179) | p-value |
---|---|---|---|
T-cell mediated | 11.6 | 5.0 | 0.02 |
• Psoriasis | 4.1 | 2.8 | |
• Non-infectious anterior uveitis | 2.9 | 0.6 | |
• Alopecia areata | 1.2 | 0 | |
• Giant cell arteritis | 0.6 | 0 | |
• Polymyalgia rheumatica | 1.2 | 0.6 | |
• Multiple sclerosis | 0.6 | 0 | |
• Psoriatic arthritis | 0.6 | 1.1 | |
• Ankylosing spondylitis | 0.6 | 0 | |
B-cell mediated | 2.9 | 2.8 | >0.99 |
• Graves’ disease | 1.7 | 0 | |
• Raynaud’s syndrome | 1.2 | 1.7 | |
• Systemic lupus erythematosus | 0 | 0.6 | |
• Meniere’s disease | 0 | 0.6 | |
Combined T-cell and B-cell mediated | 9.9 | 7.3 | 0.38 |
• Rheumatoid arthritis | 4.6 | 2.8 | |
• Juvenile rheumatoid arthritis | 1.2 | 0 | |
• Inflammatory polyarthropathy (ANA+) | 0.6 | 0 | |
• Immune thrombocytopenic purpura | 0.6 | 0 | |
• Hashimoto’s thyroiditis | 0.6 | 1.7 | |
• Autoimmune hepatitis | 0.6 | 0 | |
• Rheumatic fever | 0.6 | 0 | |
• Inflammatory bowel disease | 0.6 | 1.1 | |
• Sjogren syndrome | 0.6 | 1.7 |
Significant p-values are in bold.
Note: % Autoimmune diseases add up to higher % than the overall prevalence as some patients had multiple autoimmune diseases.
Abbreviation: ANA, anti-nuclear antibody; POAG, primary open angle glaucoma.